Grundinformationen
- CAS
26042-64-8- Standard-SMILES
[Ag+].[F][Sb-]([F])([F])([F])([F])[F]- InChIKey
GSXFODUDOAXUBF-UHFFFAOYSA-H- Summenformel
- AgF6Sb
- Durchschnittliche Molmasse
- 343,619 g/mol
- Monoisotopische Masse
- 341,79932
Namen und Bezeichner
- Bevorzugter Name
- Silver hexafluoroantimonate
- IUPAC
- silver hexafluoroantimony(1-)
- Lokaler Name
- Silberhexafluoroantimonat(1-)
- Englischer Name
- Silver hexafluoroantimonate
- Summenformel
- AgF6Sb
- Molmasse
- 343.62
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
26042-64-8- PubChem CID
- 16687962
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 0 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 7
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 8
- Formalladung
- 0
- Komplexität
- 62
Physikochemische Eigenschaften
- storage temp.
- Keep in dark place,Inert atmosphere,Room temperature
- Löslichkeit
- sol (and forms 1:2 complexes with) benzene, toluene, xylene; sol nitromethane, liq SO2; insol HF, petroleum ether.
- Aggregatzustand
- Powder/Lump
- Farbe
- White to pale yellow
- Wasserlöslichkeit
- Soluble in water.
- Stabilität
- hygroscopic
- Major Application
- PEM fuel cellsmaterial synthesis precursor
- InChI
- InChI=1S/Ag.6FH.Sb/h;6*1H;/q+1;;;;;;;+5/p-6
- InChIKey
- GSXFODUDOAXUBF-UHFFFAOYSA-H
- SMILES
- [Sb+5]([F-])([F-])([F-])([F-])([F-])[F-].[Ag+]
- CAS Datenbank
- 26042 · 26042-64-8(CAS DataBase Reference)
- EPA chemische Informationen
- Antimonate(1-), hexafluoro-, silver(1+), (OC-6-11)- (26042-64-8)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H302 (96%): Harmful if swallowed [Warning Acute toxicity, oral];H314 (22%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H332 (96%): Harmful if inhaled [Warning Acute toxicity, inhalation];H411 (92%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P260, P261, P264, P270, P271, P273, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P363, P391, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 50 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Toxikologische Informationen
Treatment
Following oral exposure to antimony, administer charcoal as a slurry (240 mL water/30 g charcoal). Following inhalation exposure, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Following dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. (T36)
Health Effects
Dermal exposure to antimony can cause antimony spots (papules and pustules around sweat and sebaceous glands). Antimony poisoning can also lead to pneumoconiosis. Alterations in pulmonary function and other effects including chronic bronchitis, chronic emphysema, inactive tuberculosis, pleural adhesions, and irritation can result from inhalation of antimony. Increased blood pressure can also result from antimony poisoning. Myocardial depression, vasodilation and fluid loss may cause shock with hypotension, electrolyte disturbances and acute renal failure. Cerebral oedema, coma, convulsions, and death are possible. Exposure to high levels of silver for a long period of time may result in a condition called arygria, a blue-gray discoloration of the skin and other body tissues. Argyria is a permanent effect but does not appear to be harmful to health. While silver itself is not toxic, most silver salts are, and may damage the liver, kidney, and central nervous system, as well as be carcinogenic. (L808, L809, L810, L741)
Toxicity Summary
The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes of the glycogenolysis and gluconeogenesis pathways. The mechanism of action of antimony remains unclear. However, some studies suggest that antimony combines with sulfhydryl groups including those in several enzymes important for tissue respiration. The antidotal action of BAL depends on its ability to prevent or break the union between antimony and vital enzymes. Moreover, the The cause of death is believed to be essentially the same as that in acute arsenic poisoning. Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions and intracellular ion concentrations, respectively. Silver nanoparticles are believed to disrupt the mitochondrial respiratory chain, causing oxidative stress, reduced ATP synthesis, and DNA damage. (L808, A243, A244, A245, A246, T18, L741, A238)
Signs and Symptoms
Abdominal pain, vomiting, diarrhea can result from inhalation of antimony. Dyspnea, headache, vomiting,cough, conjunctivitis, and bloody purulent discharge from nose can result from inhalation exposure. Skin or eye contact can cause pain and redness of the exposed surface. Exposure to high levels of silver for a long period of time may result in a condition called arygria, a blue-gray discoloration of the skin and other body tissues. Argyria is a permanent effect but does not appear to be harmful to health. Exposure to high levels of silver in the air has resulted in breathing problems, lung and throat irritation, and stomach pains. Skin contact with silver can cause mild allergic reactions such as rash, swelling, and inflammation in some people. (L808, T64, L741)
Sicherheitsdaten
- F
- 3-8-10
- wgk
- 2
- tsca
- TSCA listed
- ridadr
- UN 3260 8/PG 2
- hs_code
- 28432900
- risk_code
- 20/22-51/53
- hazard_code
- Xn,N,C
- hazard_note
- Corrosive/Hygroscopic
- safety_code
- 61
- hazard_class
- 8
- packing_group
- III
- Speicherklasse
- 8B - Non-combustible corrosive hazardous materials
- Hazard Classifications
- Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Chronic 2
Chemie und Industrie
Pharmakologische Informationen
Metabolism/Metabolites
Antimony is widely distributed throughout the body. The hair and skin contain the highest levels of antimony. The adrenal glands, lung, large intestine, trachea, cerebellum, and kidneys also contain relatively high levels of antimony. Blood is the main vehicle for the transport of absorbed antimony to various tissue compartments of the body. Antimony is a metal and, therefore, does not undergo catabolism. Antimony can covalently interact with sulfhydryl groups and phosphate, as well as numerous reversible binding interactions with endogenous ligands (e.g., proteins). It is not known if these interactions are toxicologically significant. Antimony is excreted via the urine and feces. Some of the fecal antimony may represent unabsorbed antimony that is cleared from the lung via mucociliary action into the esophagus to the gastrointestinal tract. Silver and its compounds can be absorbed via inhalation, while silver compounds can also be absorbed orally and dermally. It distributes throughout the body in the blood, particularily to the liver. Insoluble silver salts are transformed into soluble silver sulfide albuminates, bind to amino or carboxyl groups in RNA, DNA, and proteins, or are reduced to metallic silver by ascorbic acid or catecholamines. Metallic silver is oxidized and may deposit in the tissues, causing arygria. Silver is eliminated primarily in the faeces. (L808, L741)
Verwendung und Herstellung
Anwendungen
VerwendenSilver Hexafluoroantimonate(V) is used as a catalyst in the synthesis of isocoumarins through benzothiadiazine-fused.
Darstellung
synthetischeSilver hexafluoroantimonate has been made from SbF3 (or Sb2O3), AgCl, and Bromine Trifluoride, but is more readily prepared by reacting Antimony(V) Fluoride and Silver(I) Fluoride in anhydrous HF at -78 to 0 °C, washing with pet ether, and drying in vacuo.
Anbieter97 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…